(165b) Developing Precision Medicine Using Quantum Biology: Combining Quantum States, Surface Chemistry, and Microbiology
- Conference: AIChE Annual Meeting
- Year: 2017
- Proceeding: 2017 Annual Meeting
- Group: Topical Conference: Nanomaterials for Applications in Energy and Biology
Monday, October 30, 2017 - 12:55pm-1:20pm
Multidrug-resistant bacterial infections are an ever-growing threat because of the shrinking arsenal of efficacious antibiotics, and the high-frequency of multidrug-resistant (MDR) bacterial infections combined with the lack of new antibiotics threatens the future of our healthcare system as we approach a post-antibiotic era.Â An increasing class of gram-negative multidrug-resistant pathogens like Enterobacteriaceae including carbapenem-resistant (CRE)Â Escherichia coliÂ and extended spectrum Î²-lactamase (ESBL) producingÂ Klebsiella pneumoniaeÂ (KPN) are severely antibiotic resistant and were recently designated priority 1 critical class bacterial pathogens in urgent need of effective antibiotics by the World Health Organization. To address an urgent need for developing a new class of antibiotics beyond the nominal small molecule discovery, and adjuvants to work or potentiate existing antibiotics, my group is developing nanomaterial therapeutics combining quantum confined materials, surface chemistry, and microbiology. Furthermore, while using external stimulus like light has been successful in addressing issues of drug delivery and transport in metal nanoparticle based therapies, metal nanoparticles induced cell death and toxicity effect is typically nonspecific. Here, I will show a range of quantum confined nanomaterials such as quantum dots (QDs) can kill a wide range of multidrug-resistant bacterial clinical isolates, including methicillin-resistantÂ Staphylococcus aureus, carbapenem-resistantÂ Escherichia coli, and extended-spectrum Î²-lactamase-producingÂ Klebsiella pneumoniaeÂ andÂ Salmonella typhimurium. The killing effect is independent of material and controlled by the redox potentials of the photogenerated charge carriers, which selectively alter the cellular redox state. We also show that the QDs can be tailored to kill 92% of bacterial cells in a monoculture, and in a co-culture ofÂ E. coliÂ and HEK 293T cells, while leaving the mammalian cells intact, or to increase bacterial proliferation. These studies can not only lead to development of new antibiotics and adjuvants for clinical therapeutics for the treatment of infections, but also be used in the study of the effect of redox states on living systems.